Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 3/20 | 0.44 |
| ▸ | MAPK9 | P45984 | 3/20 | 0.44 |
| ▸ | RAF1 | P04049 | 1/20 | 0.44 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | KDR | P35968 | 1/20 | 0.44 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.44 |
| ▸ | MAPK11 | Q15759 | 4/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 4/20 | 0.43 |
| ▸ | MAPK13 | O15264 | 3/20 | 0.41 |
| ▸ | MAPK12 | P53778 | 3/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5816216 | 0.92 | EGFR (0.48) | EGFRMAPK9RAF1ERBB2SRC | |
| SCHEMBL5819618 | 0.91 | EGFR (0.43) | EGFRMAPK9RAF1ERBB2SRC | |
| SCHEMBL5818662 | 0.90 | KCNH2 (0.44) | EGFRMAPK9RAF1ERBB2SRC | |
| SCHEMBL5818970 | 0.84 | EGFR (0.47) | EGFRMAPK9RAF1ERBB2SRC | |
| SCHEMBL5816969 | 0.84 | KCNH2 (0.50) | EGFRMAPK9KCNH2MAPK14 | |
| SCHEMBL5814016 | 0.84 | EGFR (0.43) | EGFRMAPK9RAF1ERBB2SRC | |
| SCHEMBL5819635 | 0.83 | MAPK13 (0.62) | EGFRMAPK9RAF1ERBB2SRC | |
| SCHEMBL5819173 | 0.83 | MAPK9 (0.51) | EGFRMAPK9KCNH2 | |
| SCHEMBL5818448 | 0.82 | MAPK9 (0.50) | EGFRMAPK9KCNH2 | |
| SCHEMBL5813599 | 0.81 | KCNH2 (0.51) | KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006137658-A1 | NEW SUBSTITUTED 1,3-THIAZOLE DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF HAVING IMMUNOSUPPRESSION AND INFLAMMATION INHIBITORY ACITIVITY, INTERMEDIATE COMPOUNDS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, A PROCESS FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | DONGBU HITEK CO., LTD. (KR) | 2006-12-28 | — | — | WO | claimed |